Today@Dal

» Go to news main

19‑21 Year Old Study Participants Needed

Posted by Departement of Medicine (Pediatrics)/Canadian Center for Vaccinology on June 26, 2019 in General Announcements

Pertussis, also known as “whooping cough”, is a highly contagious respiratory disease caused by a germ called Bordetella pertussis. Pertussis vaccines are often mixed with other vaccines that protect against other illnesses such as diphtheria and tetanus. These three combined vaccines can be given as a single shot, which is called tetanus, diphtheria and pertussis vaccine or Tdap. The Tdap vaccine is part of the recommended vaccines for adults.

The Canadian Center for Vaccinology is conducting a clinical trial to test the effectiveness of a new Tdap booster when compared with the licensed Tdap vaccine, Adacel®.

Participants must be between 19-21 years of age and not received a Tdap vaccine in the past 4 years. Study participants will be reimbursed for their time.

For more information, please contact Cathy Brown, Research Coordinator: 902-470-7015. You can also visit our study page here: http://centerforvaccinology.ca/study/tdap-vaccine-study/